Can peripheral leukocytes be used as Alzheimer’s disease biomarkers? Rezai-Zadeh K, Gate D, Szekely CA, Town T. Expert Rev Neurother. 2009 Nov;9(11):1623-33. Alzheimer’s disease (AD) is the leading cause of dementia in elderly…
Use of genetic variation as biomarkers for Alzheimer’s disease. Reitz C, Mayeux R. Ann N Y Acad Sci. 2009 Oct;1180:75-96 Late-onset Alzheimer’s disease (LOAD) is the most common cause of late-onset dementia in…
Neurodegeneration in Alzheimer’s disease: caspases and synaptic element interdependence Dale E Bredesen Mol Neurodegener. 2009 Jun 26;4:27. Extensive genetic, biochemical, and histological evidence has implicated the amyloid-&豪 peptide (A&豪) in Alzheimer’s disease pathogenesis,…
Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer’s Disease George J. Brewer Exp Biol Med 232:323–335, 2007 In this review, we point out that natural selection does not act…